A BBB‐Penetrating Fullerene Mediates Recovery from Intracerebral Hemorrhage via Dually Promoting Hematoma Clearance and Neuroprotection
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yuyang Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, Institute of Chemistry, Chinese Aca…. Hauptthemen laut MEDLINE: Fullerenes, Cerebral Hemorrhage, Blood-Brain Barrier, Hematoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation Project of Jiangxi Province.
Abstract (Originalsprache)
Current pharmacologic intervention for intracerebral hemorrhage (ICH) is severely limited by insufficient blood‐brain barrier (BBB) penetration and complicated secondary injury mechanisms. To address this, we developed a multi‐pronged therapeutic strategy for ICH utilizing a BBB‐penetrating tetra malonic acid derivative of C 70 fullerene (TMF), which dually accelerates hematoma clearance and mitigates perihematomal damage. Following intravenous administration, TMF crossed the BBB via clathrin‐mediated endocytosis in cerebral microvascular endothelial cells and accumulated in brain tissue. It promoted hematoma resolution and improved motor deficits in both zebrafish and mouse ICH models. Mechanistically, TMF reduced microglial oxidative stress, leading to its polarization toward the M2 phenotype. This shift enhanced phagosome signaling and degradation functions while attenuating neuroinflammation. Additionally, TMF exhibited direct neuroprotection by resisting oxidative stress, iron toxicity, and apoptosis, collectively constituting its pleiotropic therapeutic mechanisms. In summary, this study overcomes the major challenges in ICH therapeutics, offering a promising candidate for clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences (UCAS), Beijing, China.
- Jiangxi Branch of State Key Laboratory for Macromolecule Drugs and Large-scale Preparation & National Engineering Research Center of Cell Growth Factor Drugs and Protein Biologics, Center for Genetic Development and Reg…
ORCID-Profile: Xue Li
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation Project of Jiangxi Province
- National Key Research and Development Program of China
Zitieren
APA
Peng, Y., Liu, L., Huang, Y., Ma, J., Qi, H., Liu, J., Lu, H., Li, X., & Wang, C. (2026). A BBB‐Penetrating Fullerene Mediates Recovery from Intracerebral Hemorrhage via Dually Promoting Hematoma Clearance and Neuroprotection. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71049
Vancouver
Peng Y, Liu L, Huang Y, Ma J, Qi H, Liu J, et al. A BBB‐Penetrating Fullerene Mediates Recovery from Intracerebral Hemorrhage via Dually Promoting Hematoma Clearance and Neuroprotection. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71049
BibTeX
@article{Peng2026,
author = {Peng, Yuyang and Liu, Lei and Huang, Yong and Ma, Jing and Qi, Hedong and Liu, Jingchao and Lu, Huiqiang and Li, Xue and Wang, Chunru},
title = {A BBB‐Penetrating Fullerene Mediates Recovery from Intracerebral Hemorrhage via Dually Promoting Hematoma Clearance and Neuroprotection},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71049}
}
EUVIMED